#pharmacology — Wednesday, October 07, 2026 (2 items)
| 16 | ℹ |
UBT251, a novel triple GLP-1, GIP, and glucagon receptor agonist, in adults with overweight or obesity: A multicenter, randomized phase 2 trial.
(linkinghub.elsevier.com)
|
Cell Metabolism 2026-10-07 | #clinical trial #obesity #metabolic #pharmacology #cardiovascular | |
| 9 | ℹ |
Metabolic benefits of ketohexokinase inhibition in individuals with MASLD: a randomized placebo-controlled crossover trial.
(nature.com)
|
Nature Metabolism 2026-10-07 | #steatosis #metabolism #lipidmetabolism #pharmacology |